Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?
about
Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13.Balancing early access with uncertainties in evidence for drugs authorized by prospective case series - systematic review of reimbursement decisions.Clinically meaningful benefit: real world use compared against the American and European guidelines.Indispensable benefit of independent investigator-driven research in a changing clinical trial landscape.Detailed statistical assessment of the characteristics of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) threshold rules.
P2860
Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Do Contemporary Randomized Con ...... r Meaningful Clinical Benefit?
@en
type
label
Do Contemporary Randomized Con ...... r Meaningful Clinical Benefit?
@en
prefLabel
Do Contemporary Randomized Con ...... r Meaningful Clinical Benefit?
@en
P2093
P2860
P356
P1433
P1476
Do Contemporary Randomized Con ...... r Meaningful Clinical Benefit?
@en
P2093
I F Tannock
J C Del Paggio
W M Hopman
P2860
P304
P356
10.1093/ANNONC/MDW538
P577
2016-10-13T00:00:00Z